Shop

Showing 1281–1296 of 2281 results

Article: O.1 Results from the Belgian mantle cell lymphoma registry
€3.03 Add to cart
Article: O.2 A single analysis for simultaneous measurement of all 4 DOACs
€3.03 Add to cart
Article: O.2 Analysis of Phenotype and Outcome in Essential Thrombocythemia with CALR and JAK2 mutations
€3.03 Add to cart
Article: O.2 AXL: A potential therapeutic target to eliminate cancer cells and improve chemotherapeutic responses in different hematological cancers
€3.03 Add to cart
Article: O.2 Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation
€3.03 Add to cart
Article: O.2 Nanobodies as new imaging tools in multiple myeloma: a study in the 5T2MM murine model
€3.03 Add to cart
Article: O.2 RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response
€3.03 Add to cart
Article: O.3 Comparison of 2 nonmyeloablative regimens for allogeneic HCT: a phase II randomized study from the HCT committee of the BHS
€3.03 Add to cart
Article: O.3 Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood (PB) Stem Cell Transplantation (SCT) From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies
€3.03 Add to cart
Article: O.3 IgHV Mutational Status Analysis By Next-Generation Deep Sequencing In Chronic Lymphocytic Leukemia Patients: Prognostic Significance Of Multiple Subclones And Implication For Disease Cell Origin
€3.03 Add to cart
Article: O.3 Maternal Embryonic Leucine Zipper Kinase (MELK) Drives a High-Risk Gene Network and Represents an attractive Novel Drug Target in Multiple Myeloma and its associated Bone Disease
€3.03 Add to cart
Article: O.3 Palliative cytoreduction with low dose intravenous melphalan in patients with acute myeloid leukemia refractory to prior treatment
€3.03 Add to cart
Article: O.3 The anti-angiogenic peptide Anginex blocks osteoclastogenesis
€3.03 Add to cart
Article: O.4 An in-depth investigation of the causes of treatment failure in AML
€3.03 Add to cart
Article: O.4 Combination of regulatory T cells injection with rapamycin for treatment of chronic Graft-versus-Host disease
€3.03 Add to cart
Article: O.4 Functional characterization of activating mutants of the JAK3 tyrosine kinase implicated in tumoral transformation of T lymphocytes
€3.03 Add to cart

Article: O.1 Results from the Belgian mantle cell lymphoma registry

Article: O.2 A single analysis for simultaneous measurement of all 4 DOACs

Article: O.2 Analysis of Phenotype and Outcome in Essential Thrombocythemia with CALR and JAK2 mutations

Article: O.2 AXL: A potential therapeutic target to eliminate cancer cells and improve chemotherapeutic responses in different hematological cancers

Article: O.2 Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation

Article: O.2 Nanobodies as new imaging tools in multiple myeloma: a study in the 5T2MM murine model

Article: O.2 RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response

Article: O.3 Comparison of 2 nonmyeloablative regimens for allogeneic HCT: a phase II randomized study from the HCT committee of the BHS

Article: O.3 Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood (PB) Stem Cell Transplantation (SCT) From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies

Article: O.3 IgHV Mutational Status Analysis By Next-Generation Deep Sequencing In Chronic Lymphocytic Leukemia Patients: Prognostic Significance Of Multiple Subclones And Implication For Disease Cell Origin

Article: O.3 Maternal Embryonic Leucine Zipper Kinase (MELK) Drives a High-Risk Gene Network and Represents an attractive Novel Drug Target in Multiple Myeloma and its associated Bone Disease

Article: O.3 Palliative cytoreduction with low dose intravenous melphalan in patients with acute myeloid leukemia refractory to prior treatment

Article: O.3 The anti-angiogenic peptide Anginex blocks osteoclastogenesis

Article: O.4 An in-depth investigation of the causes of treatment failure in AML

Article: O.4 Combination of regulatory T cells injection with rapamycin for treatment of chronic Graft-versus-Host disease

Article: O.4 Functional characterization of activating mutants of the JAK3 tyrosine kinase implicated in tumoral transformation of T lymphocytes